Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application

Cell Commun Signal. 2024 Apr 18;22(1):232. doi: 10.1186/s12964-024-01615-9.

Abstract

Metastasis poses a major challenge in colorectal cancer (CRC) treatment and remains a primary cause of mortality among patients with CRC. Recent investigations have elucidated the involvement of disrupted gut microbiota homeostasis in various facets of CRC metastasis, exerting a pivotal influence in shaping the metastatic microenvironment, triggering epithelial-mesenchymal transition (EMT), and so on. Moreover, therapeutic interventions targeting the gut microbiota demonstrate promise in enhancing the efficacy of conventional treatments for metastatic CRC (mCRC), presenting novel avenues for mCRC clinical management. Grounded in the "seed and soil" hypothesis, this review consolidates insights into the mechanisms by which imbalanced gut microbiota promotes mCRC and highlights recent strides in leveraging gut microbiota modulation for the clinical prevention and treatment of mCRC. Emphasis is placed on the considerable potential of manipulating gut microbiota within clinical settings for managing mCRC.

Keywords: Colorectal cancer; Gut microbiota; Metastasis; “seed and soil” hypothesis.

Publication types

  • Review

MeSH terms

  • Colonic Neoplasms*
  • Colorectal Neoplasms* / pathology
  • Gastrointestinal Microbiome*
  • Humans
  • Tumor Microenvironment